Pharmaceutical formulations for subcutaneous administration

US12251365B2 · kind B2 · utility

Assignees

• Abb Vie Inc. · US
• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Ehab Moussa · Libertyville, US
• Matthew Rosebraugh · Grayslake, US
• Feroz Jameel · Covina, US
• Nancy E. Sever · Northbrook, US
• Maurizio F. Facheris · Chicago, US
• Weining Z. Robieson · Hawthorn Woods, US
• Charles S. Locke · Gurnee, US
• Sven Stodtmann · Neustadt an der Weinstraße, DE

Key dates

• Filing date: Nov 15, 2019
• Grant date: Mar 18, 2025
• Expiry date: Jun 10, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/16
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to compositions of levodopa 4′-monophosphate and carbidopa 4′-monophosphate having a weight by weight ratio of about 20:1 and methods of treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.